Overall rank by patents
#25,484
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 17 technology areas, active 2016–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B25B (TOOLS OR BENCH DEVICES NOT OTHERWISE PROVIDED FOR, FOR FASTENING, CONNECTING, DISENGAGING OR HOLDING).
The verdict
VON holds 11 US patents across 17 technology areas, rank #25,484 of 50,000 tracked assignees.
VON ARX Ag has been granted 11 US utility patents between 2016 and 2023, placing VON ARX Ag at rank #25,484 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in B25B (TOOLS OR BENCH DEVICES NOT OTHERWISE PROVIDED FOR, FOR FASTENING, CONNECTING, DISENGAGING OR HOLDING). As a Foreign Corporation, VON ARX Ag is one of the more focused assignees in the PatentsView dataset. By volume, VON sits between Visionat International Limited (11 patents, rank #25,480) and Valencia Bioscience, Inc. (11 patents, rank #25,488) - the closest US assignees by grant volume. The composite Innovation Score of 52.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 3 in the 2015–2019 window, a +167% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. VON ARX Ag's 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark VON ARX Ag against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
VISIONAT INTERNATIONAL LIMITED
11 patents
VISUNEX MEDICAL SYSTEMS CO. LTD.
11 patents
VITO NV (VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK NV)
11 patents
VIVONIC GMBH
11 patents
VPAY, INC.
11 patents
VYGON
11 patents
Vacuum Technologies, LLC
11 patents
Valencia Bioscience, Inc.
11 patents
VON ARX AG
11 patents
What this shows VON holds 11 patents at rank #25,484, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
VON's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 10% higher than 90% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 18.2% |
| 2017 | 1 | 9.1% |
| 2020 | 1 | 9.1% |
| 2021 | 1 | 9.1% |
| 2022 | 4 | 36.4% |
| 2023 | 2 | 18.2% |
Top 15 of 17 technology areas
Overall rank by patents
#25,484
Across all tracked assignees
52.5 out of 100
How to use this portfolio
VON's 11 grants land it in the top 10% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.